Test Directory
Lupus Anticoagulant Screen
Justification
LAs are heterogeneous IgG autoantibodies that bind to phospholipids. LAs are identified by their ability to prolong clot-based assays that have reduced reagent phospholipid.
This panel employs two clot-based assays, a lupus-sensitive aPTT and dilute Russell Viper Venom time, and an antibody assay, Anticardiolipin Antibody (IgG, IgM, IgA), to screen for the presence of a lupus anticoagulant.
Lupus anticoagulant antibodies increase the risk of arterial thrombosis, venous thrombosis, thrombocytopenia and recurrent miscarriage.
Panel Component Tests
aPTT-LA (Lupus Sensitive) Russell Viper Venom Time (dilute) Anticardiolipin Antibody (IgG, IgM, IgA)STAT: < 48 hours (M-F)
Clot-based, CIA
Draw Tube: Blue Top
Draw Tube: Red Top
Sample Type: Citrated Plasma and Serum
Specimen Requirements
Sample Type | Volume Required | Minimum Volume | Stability | |
---|---|---|---|---|
PREFERRED | Citrated Plasma and Serum | Three aliquots, 1mL each (Citrated Plasma);One aliquot, 1mL (Serum) | Three aliquots, 0.5mL each (Citrated Plasma);One aliquot, 0.5mL (Serum) | Frozen (-20C): 2 weeks Frozen (-80C): 6 months |
ALTERNATIVE | - | - | - | - |
REJECTION CRITERIA | Thawed in transit, refrozen or clotted sample |
SPECIAL INSTRUCTIONS | - |
General Information
METHODOLOGY | Clot-based, CIA |
STAT TAT | < 48 hours (M-F) |
STAT TAT Performance | > 90% of results released in 48 hours |
ROUTINE TAT | < 1 week |
ALTERNATIVE NAMES | LA Screen, LAS |
DESCRIPTION | Machaon’s Lupus Anticoagulant (LA) Algorithm is based on College of American Pathologist (CAP) and International Society on Thrombosis and Haemostasis (ISTH) published LA detection guidelines. |
LIMITATIONS | - |
NORMAL RANGE | Interpretation: Normal |
ASSOCIATED TESTING | - |
REFERENCES | - |
SAMPLE REPORT | Upon request |
NEW YORK STATE APPROVED | Yes |
Test Codes
ORDER CODE | P1182 |
CPT CODE | 86147x3, 85730, 85613 |
LOINC CODE | 3181-5, 3182-3, 5076-5, 34571-0, 6303-2 |